Who owns Alnylam Pharmaceuticals?

Key details on Alnylam Pharmaceuticals (Ticker: ALNY)

Who owns Alnylam Pharmaceuticals?

Is ALNY a good stock to own? Find out who bought Alnylam Pharmaceuticals, who sold Alnylam Pharmaceuticals (ALNY) stock, and who holds a large position in Alnylam Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 9.51M $611.96M Dec. 31, 2013
T. Rowe Price Associates 3.81M $245.36M Dec. 31, 2013
Vanguard 2.97M $190.88M Dec. 31, 2013
BlackRock Fund Advisors 2.21M $142.33M Dec. 31, 2013
Franklin Resources 2.14M $137.93M Dec. 31, 2013
Wellington Management Company 2.06M $132.04M Sept. 30, 2013
Columbia Wanger Asset Management 1.91M $122.87M Dec. 31, 2013
Gilder, Gagnon, Howe & Co 1.90M $122.12M Dec. 31, 2013
HealthCor Management 1.80M $16.87M June 30, 2011
Schroder Investment Management 1.64M $105.18M Sept. 30, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.59M $102.00M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 1.49M $95.75M Dec. 31, 2013
HealthCor Management 1.45M $35.34M March 31, 2013
STATE STREET CORPORATION 1.42M $91.05M Dec. 31, 2013
Bridger Management 1.37M $33.31M March 31, 2013
CITADEL ADVISORS 1.19M $36.84M June 30, 2013
Wells Fargo & Company 1.10M $62.40M Dec. 31, 2013
BlackRock Advisors 1.10M $70.19M Sept. 30, 2013
Capital World Investors^ 1.05M $67.85M Dec. 31, 2013
Jennison Associates 1.02M $65.50M Dec. 31, 2013
Falcon Edge Capital 1000000 $64.30M Dec. 31, 2013
Camber Capital Management 1000000 $31.01M June 30, 2013
BAILLIE GIFFORD & CO 893100 $57.45M Dec. 31, 2013
NORTHERN TRUST 820785 $52.77M Dec. 31, 2013
MORGAN STANLEY 741565 $47.69M Dec. 31, 2013
Deerfield Management Company 694000 $21.51M June 30, 2013
Columbus Circle Investors 658309 $42.33M Dec. 31, 2013
Renaissance Technologies 647200 $7.16M March 31, 2012
S.A.C. Capital Advisors 620449 $19.24M June 30, 2013
TimesSquare Capital Management 602900 $38.77M Dec. 31, 2013
LORD, ABBETT & CO 584105 $37.39M Sept. 30, 2013
Broadfin Capital 581018 $6.43M March 31, 2012
Ameriprise Financial 566047 $36.23M Sept. 30, 2013
Allianz Asset Management AG 539049 $10.13M Sept. 30, 2012
Driehaus Capital Management 526286 $5.83M March 31, 2012
Abingworth 514053 $12.53M March 31, 2013
BB Biotech AG 471288 $30.30M Dec. 31, 2013
Artisan Partners Limited Partnership 443722 $28.54M Dec. 31, 2013
GOLDMAN SACHS 440750 $28.34M Dec. 31, 2013